NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 57.74

-2.7%

Nov 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (243)	6/27/2007 11:43:30 AM
From: tuck	of 507

Notable Calls highlights Cowen's ongoing support of the company, with Cowen saying that Pfizer is still behind Exubera, and that reps were talking it up at the ADA meeting: notablecalls.blogspot.com Clinician sentiment turning, eh? With the incoming ADA president -- the top dog in that field -- being against it, how does that square with reality? Anyhow, NKTR has bounced somewhat on the call, but is still below $10. I'd be a buyer at $9.50. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next